ARID1A and central nervous system cancer: Upon integrating deep targeted sequencing data, we observed that the ARID1A gene was significantly more frequently mutated in WHO grade 4 gliomas than in WHO grades 1–3 gliomas, a phenomenon that ignited our research curiosity.